Meta AnalysisID 5615
玻璃体腔注射抗VEGF药物联合曲安奈德治疗糖尿病性黄斑水肿的疗效与安全性：系统评价与Meta分析
CRD42022369945
The aim of this meta-analysis of randomized controlled trials is to compare the effect and safety of intraocular injection of anti-VEGF drugs combined with triamcinolone acetonide in the treatment of Diabetic Macular Ede
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 5615
- Evidence Id
- 14173
- Core Evidence Id
- 14173
- Source Meta Analysis Id
- 5597
- Herb2 Meta Analysis Id
- HBMA005597
- Crd Id
- CRD42022369945
- Title
- The effect and safety of intraocular injection of anti-VEGF drugs combined with triamcinolone acetonide in the treatment of Diabetic Macular Edema:A Systematic Review and Meta-analysis.
- Review Question
- The aim of this meta-analysis of randomized controlled trials is to compare the effect and safety of intraocular injection of anti-VEGF drugs combined with triamcinolone acetonide in the treatment of Diabetic Macular Edema.
- Study Type Included
- Randomized controlled trials (RCTs) will be included. The followings will be excluded: conference abstracts, RCTs, pseudo-RCTs, cohort and case-control studies, case reports, letters, systematic review, reviews, and duplicate publications
- Condition Being Studied
- Diabetic macular edema
- Participant
- Those patients with an established diagnosis of DME are included.Macular edema caused by other conditions other than diabetes are excluded.If the medicine was used in both the experimental and control groups, the study could be included. In addition to the use of DME treatment medicine, DME patients often combine with other treatment, such as hypoglycemic and antihypertensive agents and so on. If the medicine was used in both the experimental and control groups, the study could be included. If the use of this medicine is not balanced between the experimental and control groups, the study would be excluded.If the use of this medicine is not balanced between the experimental and control groups, the study would be excluded
- Animal
- Human Disease Modelled
- Intervention
- intraocular injection of anti-VEGF drugs combined with triamcinolone acetonid
- Comparator Control
- intraocular injection of anti-VEGF drugs alones
- Main Outcome
- he number of people who respond to treatment，best-corrected visual acuity (BCVA)，central macular thickness(CMT).
- Outcome Measure
- Additional Outcome
- Adverse events
- Study Method
- Systematic review
- Keyword
- Diabetes Mellitus; Diabetic Retinopathy; Humans; Injections, Intraocular; Macular Edema; Randomized Controlled Trials as Topic; Triamcinolone Acetonide
- Contact
- Xu Dahua [email protected]
- Organisational Affiliation
- Aier School of Ophthalmology, Central South University, Changsha 410000,Hunan, China.
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2022-10-24
- Registration Date
- 2022-11-04
- Anticipated Start Date
- 2022-10-25
- Anticipated Completion Date
- 2023-01-20
- Title Cn
- 玻璃体腔注射抗VEGF药物联合曲安奈德治疗糖尿病性黄斑水肿的疗效与安全性：系统评价与Meta分析
- Title En
- The effect and safety of intraocular injection of anti-VEGF drugs combined with triamcinolone acetonide in the treatment of Diabetic Macular Edema:A Systematic Review and Meta-analysis.
- Bilingual Status
- complete